Table 2 Seropositivity to individual sexually transmitted infections and risk of ovarian cancer: results from the NHS and NHSII

From: Sexually transmitted infections and risk of epithelial ovarian cancer: results from the Nurses’ Health Studies

 

Control, n

All cases

Borderline ovarian tumours

Invasive EOC

Invasive serous EOC

  

Unadjusted

Adjusteda

Adjusteda

Adjusteda

Adjusteda

  

Case, n

RR

95% CI

RR

95% CI

Case, n

RR

95% CI

Case, n

RR

95% CI

Case, n

RR

95% CI

C. trachomatis

 Negative

297

271

Ref.

Ref.

63

Ref.

208

Ref.

135

Ref.

 Positive

40

66

2.04

1.26–3.29

2.07

1.25–3.43

17

2.11

1.04–4.28

49

1.98

1.21–3.23

35

2.31

1.33–4.01

M. genitalium

 Negative

328

320

Ref.

Ref.

74

Ref.

246

Ref.

164

Ref.

 Positive

9

17

2.00

0.86–4.67

1.92

0.78–4.72

6

2.75

0.86–8.76

11

1.81

0.68–4.77

6

1.59

0.51–4.98

Herpes simplex virus, type 2

 Negative

308

299

Ref.

Ref.

68

Ref.

231

Ref.

152

Ref.

 Positive

29

38

1.36

0.81–2.28

1.38

0.79–2.42

12

2.04

0.92–4.54

26

1.24

0.69–2.26

18

1.32

0.68–2.59

HPV16 E6 or HPV18 E6+E7 or HPV45 E6+E7

 Negative

330

326

Ref.

Ref.

77

Ref.

249

Ref.

164

Ref.

 Positive

7

11

1.57

0.61–4.05

1.23

0.44–3.44

3

2.03

0.47–8.77

8

1.37

0.47–3.99

6

1.84

0.58–5.88

  1. CI confidence interval, EOC epithelial ovarian cancer, HPV human papillomavirus, NHS Nurses’ Health Study, RR relative risk
  2. aConditional logistic regression models for all cases; all other results are from unconditional logistic regression models additionally controlling for matching factors (year of birth (±1 year), menopausal status at diagnosis (premenopausal, postmenopausal, unknown), and factors at one or both blood draws: menopausal status (premenopausal, postmenopausal, unknown), month of collection (±1 month), time of day (±2 h), fasting status (>8, ≤8 h), and postmenopausal hormone use (yes/no). Premenopausal NHSII cases and controls additionally matched on luteal day at blood collection (date of next menstrual cycle minus date of blood draw, ±1 day)). All adjusted models adjusted for: parity (nulliparous, 1 pregnancy, 2 pregnancies, 3 pregnancies, 4+ pregnancies), oral contraceptive use (never, <1 year, 1–5 years, 5+ years), tubal ligation (yes, no), marital status (never, married/domestic partnership/living with partner, divorced/separated, widowed), and weight change between ages 18 years and blood collection (kg, continuous)